Session Type: ASN Community Activity

ASN Membership Perspectives on Diversity and Inclusion: Are We There Yet?, Organized by the ASN Minority and Diversity Affairs Committee

Tuesday, June 14, 2022

4:00 PM – 5:30 PM ET

Chair(s)

DR

Deshanie Rai

Vice President, Global Scientific Regulatory and Medical Affairs
OmniActive Health Technologies

Disclosure information not submitted.
Ashley Toney, PhD

Postdoctoral Research Fellow
UTHealth Science Center at Houston, School of Public Health - El Paso, TX
El Paso, Texas, United States

Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

Speaker(s)

Liliana Aguayo-Markes, PhD, MPH

Research Assistant Professor
Emory University, Rollins School of Public Health
Atlanta, Georgia, United States

Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Jamy Ard, MD

Professor, Epidemiology & Prevention
Wake Forest School of Medicine, Department of Epidemiology and Prevention
Winston Salem, North Carolina, United States

Disclosure(s): Boehringer Ingelheim: Consultant (Terminated); Grant/Research Support (Terminated)
Calibrate: Consultant (Ongoing)
Eli Lilly: Consultant (Ongoing); Grant/Research Support (Ongoing)
Epitome: Consultant (Ongoing); Grant/Research Support (Ongoing)
KVK Tech: Grant/Research Support (Ongoing)
Level2: Consultant (Ongoing)
Nestle Healthcare Nutrition: Consultant (Ongoing); Grant/Research Support (Ongoing)
Novo Nordisk: Consultant (Ongoing)
United Health R&D: Consultant (Ongoing); Grant/Research Support (Ongoing)
WW: Grant/Research Support (Ongoing)

Moderator(s)

April Stull, PhD, RDN, FAND

Associate Professor, Human Sciences and Design
Baylor University
Waco, Texas, United States

Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.

Disclosure(s):

Ashley M. Toney, PhD: No relevant financial relationship(s) with ineligible companies to disclose.

Liliana Aguayo-Markes, PhD, MPH: No relevant financial relationship(s) with ineligible companies to disclose.

Jamy D. Ard, MD: Boehringer Ingelheim: Consultant (Terminated); Grant/Research Support (Terminated)
Calibrate: Consultant (Ongoing)
Eli Lilly: Consultant (Ongoing); Grant/Research Support (Ongoing)
Epitome: Consultant (Ongoing); Grant/Research Support (Ongoing)
KVK Tech: Grant/Research Support (Ongoing)
Level2: Consultant (Ongoing)
Nestle Healthcare Nutrition: Consultant (Ongoing); Grant/Research Support (Ongoing)
Novo Nordisk: Consultant (Ongoing)
United Health R&D: Consultant (Ongoing); Grant/Research Support (Ongoing)
WW: Grant/Research Support (Ongoing)

April J. Stull, PhD, RDN, FAND: No relevant financial relationship(s) with ineligible companies to disclose.

This session is designed to provoke thoughtful discussions about diversity and inclusion from the perspective of ASN members, representing various backgrounds (e.g., career level, educational attainment, gender, race/ethnicity), to solicit viewpoints, identify opportunities and challenges, discuss pain points, and other topics important for the promotion and sustainability of diversity and inclusion of ASN members (present and prospective) and the association’s contributions to nutritional science.